Actively Recruiting
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial
Led by Young-Hak Kim, MD, PhD · Updated on 2023-04-05
1000
Participants Needed
7
Research Sites
707 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate safety and effectiveness of CTP(computed tomography perfusion) guided revascularization vs FFR(Fractional flow reserve) guided revascularization
CONDITIONS
Official Title
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 20 and more
- Diagnosed angina or angina equivalent symptom or positive exercise treadmill test
- Patients with intermediate- or high-risk probability of CAD defined by Diamond and Forester
- 70 % stenosis or more in coronary CTA
- Willing to provide informed, written consent
You will not qualify if you...
- Requirement for surgical procedure
- Cardiogenic shock and/or need for mechanical/pharmacologic hemodynamic support
- Recent STEMI (<5 days)
- Non STEMI, if the cardiac troponin is not stable or starting to decline
- Left ventricular ejection fraction <30%
- Life expectancy <2 years
- Impaired renal function with an effective glomerular filtration rate less than 30mL/min/1.73 �b2 or creatinine more than 2.0 mg/dL
- Undergoing evaluation for organ transplantation
- Participation or planned participation in another cardiovascular clinical trial
- Pregnancy
- Inability to take dual antiplatelet therapy for six months
- Previous CABG
- Left main disease requiring revascularization
- Any target lesion with in-stent restenosis
- NYHA class 3 or 4a
- Severe and persistent angina with severe limitation in everyday living activities (Canadian Cardiovascular Society grading Class IV)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Asan Medical Center
Seoul, Songpa-Gu, South Korea
Actively Recruiting
2
Hallym University Sacred Heart Hospital
Anyang, South Korea
Completed
3
Gangwon National Univ. Hospital
Chuncheon, South Korea
Completed
4
Keimyung University Dongsan Medical Center
Daegu, South Korea
Completed
5
Pusan National University Hospital
Pusan, South Korea
Enrolling by Invitation
6
Pusan National University Yangsan Hospital
Pusan, South Korea
Completed
7
Severance Hospital
Seoul, South Korea
Withdrawn
Research Team
Y
Young-Hak Kim, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here